Cyclacel Pharmaceuticals' Series B Round

Cyclacel Pharmaceuticals raised a round of funding on May 10, 1999.

Cyclacel Pharmaceuticals is a biotechnology company developing novel cell-based immunotherapeutic treatments for cancer and infectious disease.…

Articles about Cyclacel Pharmaceuticals' Series B Round: